Wellington Management Group LLP Viking Therapeutics, Inc. Transaction History

Wellington Management Group LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$47.39 - $80.2 $221,026 - $374,052	4,664 Added 13.26%	39,835 $2.11 Million
Q1 2024 May 15, 2024	BUY	$17.4 - $94.5 $611,975 - $3.32 Million	35,171 New	35,171 $2.88 Million
Q1 2023 May 12, 2023	BUY	$8.08 - $17.33 $1.33 Million - $2.85 Million	164,288 New	164,288 $2.74 Million
Q1 2020 May 14, 2020	SELL	$3.45 - $7.95 $214,203 - $493,599	-62,088 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$6.38 - $8.73 $396,121 - $542,028	62,088 New	62,088 $498,000

476

63.4M

5.76M

3.39M

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.5B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.